GSK reaffirmed its 2025 outlook and said it was "well positioned" to absorb potential U.S. pharmaceutical tariffs, after ...

GSK and Smith & Nephew outperformed forecast-beating Barclays today as the FTSE 100 index stayed within reach of a 13th consecutive improvement. London’s top flight stood 5.10 points lower at 8458.36, ...